Copyright
©The Author(s) 2022.
World J Hepatol. Jun 27, 2022; 14(6): 1226-1234
Published online Jun 27, 2022. doi: 10.4254/wjh.v14.i6.1226
Published online Jun 27, 2022. doi: 10.4254/wjh.v14.i6.1226
Table 1 Demographics of subjects
Variables | ALL (n = 437) | Fatty liver (n = 110) | Non-fatty liver (n = 327) | P value |
Gender (Male/Female) | 269/168 | 80/30 | 189/138 | 0.005 |
Age (yr) | 74.0 ± 13.0 | 64.7 ± 13.0 | 77.1 ± 11.0 | < 0.001 |
Height (cm) | 159.4 ± 10.2 | 163.2 ± 10.0 | 158.2 ± 9.9 | < 0.001 |
Body weight (kg) | 61.3 ± 14.5 | 70.0 ± 16.6 | 58.5 ± 12.5 | < 0.001 |
BMI (kg/m2) | 24.0 ± 4.9 | 26.0 ± 4.7 | 23.3 ± 4.7 | < 0.001 |
HbA1c (%) | 7.0 ± 1.2 | 7.2 ± 1.2 | 6.9 ± 1.2 | 0.066 |
Blood glucose (mg/dl) | 164 ± 80 | 170 ± 116 | 161 ± 63 | 0.297 |
White blood cells (/μL) | 6618 ± 2299 | 7056 ± 1649 | 6470 ± 2463 | 0.021 |
Hemoglobin (g/dL) | 12.6 ± 2.4 | 14.2 ± 2.1 | 12.0 ± 2.2 | < 0.001 |
Platelets (104/μL) | 20.7 ± 7.0 | 20.4 ± 5.5 | 20.8 ± 7.4 | 0.615 |
Prothrombin time (%) | 89.6 ± 22.3 | 89.2 ± 23.6 | 89.7 ± 22.1 | 0.895 |
Albumin (g/dL) | 3.7 ± 0.7 | 3.9 ± 0.6 | 3.6 ± 0.6 | < 0.001 |
Total bilirubin (mg/dL) | 0.76 ± 0.50 | 0.86 ± 0.49 | 0.72 ± 0.49 | 0.015 |
ALP (U/L) | 266 ± 156 | 247 ± 80 | 272 ± 176 | 0.182 |
AST (U/L) | 25.3 ± 22.8 | 29.0 ± 20.2 | 23.0 ± 23.4 | 0.014 |
ALT (U/L) | 23.5 ± 20.8 | 35.0 ± 27.4 | 19.0 ± 16.1 | < 0.001 |
GGT (U/L) | 46.2 ± 63.1 | 68.0 ± 74.4 | 38.0 ± 56.6 | < 0.001 |
Creatinine (mg/dL) | 1.71 ± 2.10 | 1.27 ± 1.58 | 1.85 ± 2.22 | 0.012 |
eGFR (mL/min) | 52.0 ± 29.2 | 58.9 ± 21.9 | 49.6 ± 30.9 | 0.004 |
Total cholesterol (mg/dL) | 181 ± 50 | 193 ± 64 | 177 ± 43 | 0.012 |
HDL cholesterol (mg/dL) | 53 ± 17 | 50 ± 15 | 54 ± 17 | 0.039 |
Triglyceride (mg/dL) | 160 ± 179 | 228 ± 299 | 134 ± 87 | < 0.001 |
LDL cholesterol (mg/dL) | 101 ± 36 | 111 ± 40 | 96 ± 33 | 0.001 |
FIB-4 index | 2.20 ± 1.56 | 1.84 ± 1.08 | 2.32 ± 1.67 | 0.005 |
Cirrhosis (%) | 8 (1.8) | 1 (0.9) | 7 (2.1) | 0.405 |
Hepatocellular carcinoma (%) | 7 (1.6) | 1 (0.9) | 6 (1.8) | 0.504 |
Cerebrovascular accident (%) | 45 (10) | 9 (8.2) | 36 (11) | 0.399 |
Cardiovasculart disease (%) | 137 (31) | 29 (26) | 108 (33) | 0.193 |
Dyslipidemia (%) | 205 (47) | 53 (48) | 152 (46) | 0.758 |
Hypertension (%) | 270 (62) | 57 (51) | 213 (65) | 0.013 |
Dialysis (%) | 45 (10) | 3 (2.7) | 42 (12) | 0.003 |
Table 2 Multivariate analysis for factors associated with fatty liver
Variables | Odds ratio | 95% confidence interval | P value |
Age | 0.945 | 0.922-0.969 | < 0.001 |
Hemoglobin | 1.501 | 1.278-1.764 | < 0.001 |
HDL cholesterol | 0.971 | 0.953-0.989 | 0.002 |
Dialysis | 0.109 | 0.014-0.856 | 0.035 |
- Citation: Yamane R, Yoshioka K, Hayashi K, Shimizu Y, Ito Y, Matsushita K, Yoshizaki M, Kajikawa G, Mizutani T, Watarai A, Tachi K, Goto H. Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus. World J Hepatol 2022; 14(6): 1226-1234
- URL: https://www.wjgnet.com/1948-5182/full/v14/i6/1226.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i6.1226